Navigation Links
Cancer research partnership between UCSF, MMRF to drive drug development
Date:5/29/2009

The University of California, San Francisco (UCSF) and the Multiple Myeloma Research Foundation (MMRF) have established the Stephen and Nancy Grand Multiple Myeloma Translational Initiative, a research collaboration dedicated to translating basic science discoveries into new candidate drugs for testing in clinical trials.

The initiative, known as MMTI, was launched with a $2 million gift from Stephen and Nancy Grand of San Francisco. Mr. Grand, age 65, is a multiple myeloma patient at the UCSF Helen Diller Family Comprehensive Cancer Center.

The MMTI, a collaboration comprised of UCSF basic scientists, clinical researchers and clinicians, will be led by Jeffrey Wolf, MD, director of the Multiple Myeloma Program at the UCSF Helen Diller Family Comprehensive Cancer Center. The basic science research arm will be led by UCSF's Peter Walter, PhD, an investigator with the Howard Hughes Medical Institute and the lead scientist on a Collaborative Innovation Award from HHMI that will help drive the initiative.

"Through the MMRF's drive to identify barriers slowing drug discovery and development, we saw a critical need to champion the growth of translational research in multiple myeloma," said Louise M. Perkins, PhD, chief scientific officer of the MMRF. "By partnering with UCSF to create the business plan for the MMTI, we are enabling the more rapid development of the next generation of treatments for multiple myeloma, and providing a blueprint for translational initiatives that can serve as models for advancing research in other cancers and diseases."

Multiple myeloma is an incurable cancer of the bone marrow. The five-year relative survival rate is about 38 percent, one of the lowest of all cancers. In 2008, an estimated 19,920 adults -- 11,190 men and 8,730 women -- in the United States were diagnosed with multiple myeloma and an estimated 10,690 people died from the disease.

"Although we have made much progress in deli
'/>"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
2. Falcon Genomics Awarded Patent for Innovative Cancer Test
3. Cancer cells need normal, nonmutated genes to survive
4. The vulnerable cancer cell
5. New survey highlights growing concern about risk of infection in cancer patients
6. Cancer Survivors Can Still Be Fit, Study Asserts
7. New blood test greatly reduces false-positives in prostate cancer screening
8. Cardiovascular fitness not affected by cancer treatment
9. Cottonseed-based drug shows promise in treating severe brain cancer
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheBayAreaAirQualityManagementDistrictisissui... Alert forThursday,November26,2009whichbansburn...thindoorsandoutdoors. ,, "Cold,stillweatherwill...roadbent,executiveofficeroftheAirDistrict."We,reas...borsandfellowcommunitymembersthisThanksgiving,andn...
(Date:11/25/2009)...e? This simple question has been the focus of int...gene Modulates High Blood Pressure in Mice & Men,... question has been the focus of intense research f... time established a link between a novel gene, pho...in mice as well as humans. The studies were direct...
(Date:11/25/2009)...cal symptoms, study finds , , WEDNESDAY...fects are among the potential problems faced by lo...eated with cisplatin-based chemotherapy, a new stu...ian men treated for unilateral testicular cancer b...survey conducted from 1998 to 2002. , The resea...
(Date:11/25/2009)...ne carried into the body on a carefully engineered...fully eliminate tumors in mammals, scientists repo... Medicine . , The new approach, pioneered by bio... uses plastic disks impregnated with tumor-specifi...am the mammalian immune system to attack tumors. T...
(Date:11/25/2009)... Imaging Services, known as one of the largest ind...g equipment, now offering a total solution for dia...rvice and installation with acquisition of Kosmic ...alifornia) , Brick, NJ (P...ices is proud to announce its acquisition of Kosmi...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...f its mission,to provide service, support and hope...tion of America (LFA) submitted comments today to ... Administration (SSA), regarding a,proposed change...nce to be submitted 5 days,before an administrativ...
...a Corporation,(Nasdaq: HSKA ) today announced its...has amended its bovine vaccine distribution agreem...ka Corporation ("Heska" or the,"Company") reports ...a Des Moines agreed to fund a portion of developme...
...8, 2007 A review published in Dermatologic Therap...osmetic procedures in the same way as women but re.... , There has recently become a growing interest... , Men often require more units of Botox than wom...
...r 28, 2007 Cosmecueticals, beauty aids that repor...new ways to treat aging skin. A study recently pub...ores a variety of new ingredients in cosmeceutical...ularity, formation of wrinkles, and increased pres...
... Versus,Technology, Inc. ("Versus" or the "Company... quarter ended October 31, 2007, compared to,reven...enues for the year,ended October 31, 2007, were $5...customer projects. Accordingly, revenues,reported ...
... Software,Corporation (OTC Bulletin Board: MBSB) a...th Keystone Equity Partners to issue 490.196 share...xchange for the cancellation of,approximately $1,5...regate of 2,500,000 shares of common stock,upon th...
Other Medicine News:Health News:Lupus Foundation of America Urges Social Security Administration Not to Adopt Proposed 5-Day Rule 2Health News:Heska Announces Amended Agreement With AgriLabs 2Health News:Heska Announces Amended Agreement With AgriLabs 3Health News:Versus Technology Announces Fourth Quarter Results 2Health News:Versus Technology Announces Fourth Quarter Results 3Health News:Versus Technology Announces Fourth Quarter Results 4Health News:Versus Technology Announces Fourth Quarter Results 5Health News:Versus Technology Announces Fourth Quarter Results 6Health News:Versus Technology Announces Fourth Quarter Results 7Health News:MB Software Corporation Reaches Agreement with Keystone Equity Partners 2
(Date:11/25/2009)...Newswire-FirstCall/--Formanyofthemillionsofhearing...untreated hearingloss ,theholidaysmaynotbeallthath...iorvicepresidentofHearUSA(Amex: EAR ),oneofAmerica...studieshavelinkedhearinglosstostress,frustration,a...lidaygatheringswithfamiliesandfriends,whenmanyofth...
(Date:11/25/2009)...ewswire/--RegadoBiosciences,aprivatelyheldcompanyl...tivecontrolagents,announcedthatDavidMazzo,PhD,CEOa...nnualHealthCareConferenceattheNewYorkPalaceHotelin...0pm(EST)onTuesday,December1andwillincludeanovervie...pmentprogram,theanticoagulantsystem,REG1.Thehealth...
(Date:11/25/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...quipment-AGlobalMarketPerspective ,, http://...t---A-Global-Market-Perspective.html ,, Rising...elopingnationsisaprincipalfactorinfluencinggrowthi...aboutbreastcancerhasallowedwomentocomeforwardforth...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 1Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 3MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 1MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 2Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 1Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 2Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 3
...s treatment for common orthopaedic conditions , ,...the Orthopaedic Research and Education Foundation ...s who are closing the gap between basic research a...f the American Academy of Orthopaedic Surgeons (...ve been working towards new treatment for the foll...
...ate company developing novel biomarkers and diagno...hat it has signed an agreement with Wyeth Pharmace... assays designed to measure levels of beta amyloid...ssays for specific beta amyloid targets for use in...zheimer,s disease. The multiyear agreement include...
Other Medicine Technology:Applying Clinical Findings to the Practice of Medicine 2Applying Clinical Findings to the Practice of Medicine 3Applying Clinical Findings to the Practice of Medicine 4Applying Clinical Findings to the Practice of Medicine 5Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimer's Biomarker Assay 2
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: